Study objectives: Nitric oxide (NO), a potent vasodilator, is present
in the exhaled air of humans. We wished to quantify NO production in p
atients with abnormalities of the pulmonary circulation, Participants:
Nine patients with primary pulmonary hypertension (PPH), six with pul
monary fibrosis (PF), and 20 normal volunteers were studied, Intervent
ions: All subjects were studied at rest and during continuous incremen
tal (ramp) cycle ergometry exercise, All patients with PPH and nine ma
tched normal volunteers also performed constant exercise at equal abso
lute work rates, Measurements and results: The concentration of NO was
measured continuously in mixed expired air, and the rate of NO produc
tion (VNO) calculated, Peak exercise capacity was markedly impaired in
both patient groups, VNO was similar at rest in the PPH patients (142
+/-84 nL/min) and the normal subjects (117+/-45 nL/min), but lower in
the PF patients (66+/-13 nL/min; p<0.05; analysis of variance with Bon
feronni correction), While VNO in normal subjects more than doubled by
peak exercise to 268+/-85 nL/min, there was no significant rise with
exercise in either patient group (PPI-I, 155+/-81 nL/min; PF, 91+/-67
nL/min), Constant work rate exercise induced a significant rise in VNO
in the normal subjects (rest, 101+/-68 nL/min; exercise, 147+/-87 nL/
min; p<0.001) but no significant change in the PPH patients (rest, 127
+/-111 nL/min; exercise, 68+/-65 nL/min), Conclusions: We conclude tha
t the low resting VNO in PF may be due to loss of normal functional pu
lmonary capillary bed, The increase in VNO seen in normal subjects may
be associated with dilatation and recruitment of the pulmonary capill
ary bed during exercise, and failure to increase VNO during exercise i
n disease states may reflect an inability to recruit the capillary bed
.